GENFIT Receives Positive Safety Review for NASH Candidate Elafibranor

GENFIT announced on 4/23/18 that the Data Safety Monitoring Board (DSMB) issued a new positive recommendation for the continuation of the RESOLVE-IT Phase 3 trial evaluating elafibranor in NASH without any modifications.